Institute of Pathology, Rikshospitalet, N-0027, Oslo.
Platelets. 1994;5(2):96-104. doi: 10.3109/09537109409005519.
A major challenge in the use of artificial materials for implant devices, artificial organs, and extra-corporeal circulation systems, is the adhesion of platelets and the subsequent formation of platelet aggregates on the non-biological surface. The mechanism of platelet attachment to artificial surfaces is not completely understood. Using an enzyme immunoassay, we examined platelet deposition to the polystyrene plastic of microtiter plate wells under static conditions. Following thrombin stimulation, platelets adhered to the wells. This adhesion process was suppressible by the use of different substances known to interfere with the function of the platelet surface glycoprotein IIb/IIIa complex (GPIIb/IIIa). The substances we used were ethylenediaminetetraacetic acid (EDTA), tetrapeptide RGDS (Arg-Gly-Asp-Ser), and a monoclonal antibody directed against the IIIa moiety of the GPIIb/IIIa complex. Our results indicate that the GPIIb/IIIa complex is the platelet receptor which mediates platelet adhesion to polystyrene plastic under such static conditions. The GPIIb/IIIa complex should consequently be regarded as a multifunctional platelet regulator which, depending on the circumstances, may support platelet adhesion as well as platelet aggregation. By contrast, a monoclonal antibody directed against the platelet surface glycoprotein complex Ib/IX (GPIb/IX) did not under the same static conditions inhibit platelet deposition to the polystyrene plastic. In the microtiter wells, platelet alpha-granular proteins were detected either on the surface of adherent platelets or, when platelet deposition was inhibited by EDTA directly on the polystyrene plastic. In the latter case, fibrinogen and thrombospondin were definitely the dominating proteins. The presence of platelet-derived proteins in the microtiter wells significantly enhanced the adhesion of thrombin-stimulated platelets but not of non-stimulated platelets.
在将人工材料用于植入装置、人工器官和体外循环系统时,一个主要的挑战是血小板在非生物表面上的黏附以及随后形成的血小板聚集。血小板附着于人工表面的机制尚未完全阐明。我们使用酶免疫分析法,在静态条件下研究了血小板在聚苯乙烯微量滴定板孔中的沉积。在凝血酶刺激后,血小板黏附于孔中。这种黏附过程可通过使用不同的物质来抑制,这些物质已知可以干扰血小板表面糖蛋白 IIb/IIIa 复合物(GPIIb/IIIa)的功能。我们使用的物质是乙二胺四乙酸(EDTA)、四肽 RGDS(精氨酸-甘氨酸-天冬氨酸-丝氨酸)和针对 GPIIb/IIIa 复合物 IIIa 部分的单克隆抗体。我们的结果表明,GPIIb/IIIa 复合物是介导血小板在这种静态条件下黏附于聚苯乙烯塑料的血小板受体。GPIIb/IIIa 复合物因此应被视为多功能血小板调节剂,根据情况,它可能支持血小板黏附以及血小板聚集。相比之下,在相同的静态条件下,针对血小板表面糖蛋白复合物 Ib/IX(GPIb/IX)的单克隆抗体并没有抑制血小板沉积到聚苯乙烯塑料上。在微量滴定孔中,黏附的血小板表面或直接在 EDTA 抑制血小板沉积的聚苯乙烯塑料上检测到血小板α-颗粒蛋白。在后一种情况下,纤维蛋白原和血栓调节蛋白显然是主要的蛋白质。血小板衍生蛋白在微量滴定孔中的存在显著增强了凝血酶刺激的血小板的黏附,但对未刺激的血小板没有增强作用。